Weave Communications sets 22 October stockholder vote on its sale to Francisco Partners

Weave Communications sets 22 October stockholder vote on its sale to Francisco Partners

25 September 2026 — Weave Communications, which sells patient communication, scheduling and payments software to small and medium-sized healthcare practices, filed its definitive merger proxy with the US Securities and Exchange Commission on 25 September 2026. It calls a special meeting of stockholders for Thursday 22 October 2026 at 10:00 a.m. Eastern Time, held online, to vote on the company's sale to affiliates of Francisco Partners, a technology-focused investment firm. Stockholders of record at the close of business on 14 September may vote.

The deal as the parties state it

• Weave and Francisco Partners announced the agreement on 18 August 2026. The merger agreement is between Weave and Willow Parent, LLC and its subsidiary Willow Merger Sub, Inc., both affiliates of Francisco Partners.
• Stockholders are to receive $7.40 in cash per share. The announcement, issued by Weave and published by Francisco Partners, put the aggregate equity valuation at about $650 million.
• Weave's board unanimously recommends a vote in favour.
• Completion needs a majority of outstanding shares, expiry of the US Hart-Scott-Rodino waiting period, and approvals from certain other antitrust and foreign-investment authorities that the proxy does not name individually.
• Weave expects the deal to close in the fourth quarter of 2026. The agreement's outside date is 18 February 2027, extended automatically to 18 May 2027.
• After closing, Weave will leave the New York Stock Exchange and become a private company. The announcement says it will keep operating under the Weave name, with headquarters in Lehi, Utah.

Weave says more than 40,000 practice locations use its software, which connects to practice management systems to handle patient calls and texts, scheduling, insurance verification and payments.

Why it matters to customers

A change of owner does not change existing contracts by itself, and neither party has announced changes to products or pricing. Take-private deals by investment firms are, however, often followed by reviews of pricing, packaging and product focus. Francisco Partners said it sees opportunity in "continued product innovation"; Weave's chief executive pointed to more investment in AI, payments and revenue-cycle tools.

Who is affected

Healthcare practices using Weave, the practice-management vendors it integrates with, and resellers and consultants who recommend it.

What to do

• Check your Weave agreement for renewal dates, price-increase limits and change-of-control or assignment clauses, and note them before closing.
• In the US, confirm that your business associate agreement and data-processing terms will carry over to the new owner unchanged.
• If payments run through Weave, check processing rates and notice periods for changes.
• Keep an export of patient communication settings and templates, so a future switch would not start from nothing.

Sources

• US SEC EDGAR: Weave Communications, Inc., definitive proxy statement (Schedule 14A, DEFM14A) — 25 September 2026
• Francisco Partners: Weave Announces Acquisition by Francisco Partners — 18 August 2026
• Weave: Weave Announces Acquisition by Francisco Partners — 18 August 2026